Literature DB >> 8418318

Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography.

M Fujii1, S Adachi, T Shimizu, S Hirota, M Sako, M Kono.   

Abstract

Interstitial lung disease (ILD) is a frequent manifestation of rheumatoid arthritis (RA), and it has a close bearing on the prognosis of RA patients. Computed tomography (CT) has been shown to be excellent for the diagnosis of diffuse lung disease. In this study chest radiographs and high-resolution CT (HRCT) scans were obtained in 91 patients with RA to evaluate their ILD precisely. By HRCT 43 patients could be diagnosed as having interstitial pneumonitis (IP), and 5 could be diagnosed as having bronchiolitis. The remaining 43 patients were normal by HRCT. Chest radiographic findings were consistent with the HRCT findings in approximately 50% of patients with IP. HRCT was superior to chest radiographs for the detection of early interstitial changes. The histogram of HRCT values might be a useful adjunct to HRCT diagnosis by adding some degree of objectivity. HRCT is useful for the diagnosis of ILD in patients with RA.

Entities:  

Mesh:

Year:  1993        PMID: 8418318

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  13 in total

1.  Pulmonary involvement in early rheumatoid arthritis patients.

Authors:  Hisham M Habib; Ashraf A Eisa; Waleed R Arafat; Mohamed A Marie
Journal:  Clin Rheumatol       Date:  2010-05-26       Impact factor: 2.980

2.  Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.

Authors:  Radhakrishnan S Jisha; Lilly Aswathy; Vijay H Masand; Jayant M Gajbhiye; Indira G Shibi
Journal:  In Silico Pharmacol       Date:  2017-10-12

3.  Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.

Authors:  J K Dawson; H E Fewins; J Desmond; M P Lynch; D R Graham
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.

Authors:  F Figen Ayhan-Ardic; Oznur Oken; Z Rezan Yorgancioglu; Nilgun Ustun; F Dilek Gokharman
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

5.  Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis.

Authors:  J K Dawson; H E Fewins; J Desmond; M P Lynch; D R Graham
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 6.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

7.  Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.

Authors:  Bogdan Batko; Karol Urbański; Jerzy Świerkot; Piotr Wiland; Filip Raciborski; Mariusz Jędrzejewski; Mateusz Koziej; Marta Cześnikiewicz-Guzik; Tomasz J Guzik; Marcin Stajszczyk
Journal:  Clin Rheumatol       Date:  2019-05-10       Impact factor: 2.980

8.  Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.

Authors:  Jon T Giles; Sonye K Danoff; Jeremy Sokolove; Catriona A Wagner; Robert Winchester; Dimitrios A Pappas; Stanley Siegelman; Geoff Connors; William H Robinson; Joan M Bathon
Journal:  Ann Rheum Dis       Date:  2013-05-28       Impact factor: 19.103

Review 9.  [Internist's therapy of rheumatoid arthritis].

Authors:  W Seidel; M Pierer; H Häntzschel
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis.

Authors:  B Cortet; R M Flipo; M Rémy-Jardin; P Coquerelle; B Duquesnoy; J Rêmy; B Delcambre
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.